Groups | Control | EGCG | Fl | EGCG + Fl |
---|
SOD (min/mg protein) | 12.40 ± 0.37a | 13.89 ± 0.29a | 8.69 ± 0.19b | 10.23 ± 0.18c |
CAT (min/mg protein) | 68.30 ± 7.09a | 69.12 ± 11.37a | 38.47 ± 9.31b | 54.25 ± 10.09c |
GPx (min/mg protein) | 11.39 ± 0.45a | 12.96 ± 0.84a | 7.32 ± 0.21b | 10.71 ± 0.43c |
GST (min/mg protein) | 10.26 ± 0.39a | 10.60 ± 0.57a | 8.03 ± 0.16b | 10.42 ± 0.37c |
GR (μg/mg protein) | 30.73 ± 6.89a | 32.09 ± 6.71a | 20.21 ± 4.55b | 27.38 ± 0.71c |
G6PD (μg/mg protein) | 0.63 ± 0.07a | 0.53 ± 0.08b | 0.48 ± 0.06c | 065. ± 0.09d |
- Values are given as mean ± SD from six rats in each group. a, b, cValues with different superscript letters (a–c) in the same row differ significantly at p < 0.05 (DMRT)
- SOD—one unit of enzyme activity was taken as the enzyme reaction, which gave 50% inhibition of NBT reduction in 1 min/mg protein. CAT—μmol of H2O2 utilized/min/mg protein. GPx—μg of GSH consumed/min/mg protein. GST—μmol of CDNB-GSH conjugate formed/min/mg protein. GR—nmol of NADPH oxidized/min/mg protein. G6PD were expressed as nmol of NADPH formed/min/mg protein
- aValues do not differ significantly from control and EGCG group at (p < 0.05)
- bValues differ significantly from control and drug control group at (p < 0.05)
- cValues differ significantly from Fl group at (p < 0.05)